If you have been diagnosed with CSID, ask your GI doctor if Sucraid® is right for you.
Figure 1. Range of GI symptoms present in twenty-three children when diagnosed with CSID.1
Indeed, symptoms persist in adults. However, GI symptoms associated with CSID can vary. For example, GI symptoms experienced by adults may not be as severe as the GI symptoms experienced by children.1
In some adults, the symptoms may be limited to an increase in bowel movement (BM) frequency, reduced stool consistency (looser stools or watery stools), abdominal distention (bloating/swelling), and flatulence (gas). Episodic watery diarrhea may also occur after eating a meal that contains high levels of sucrose. In some individuals affected with CSID, diarrhea may alternate with constipation, particularly when taking common antidiarrheal medications, which may lead to a misdiagnosis of another GI condition, such as alternating or mixed-type irritable bowel syndrome (IBS-A).1
Individuals with Congenital Sucrase-Isomaltase Deficiency (CSID) typically have one or more of the following symptoms:
Since CSID is an inherited disorder, other family members may also be affected:
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Sucraid® (sacrosidase) Oral Solution is an enzyme replacement therapy for the treatment of genetically determined sucrase deficiency, which is part of
Congenital Sucrase-Isomaltase Deficiency (CSID).